Biocept, Inc. Profile Avatar - Palmy Investing

Biocept, Inc.

Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthc…

Medical - Diagnostics & Research
US, San Diego [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of BIOC's Analysis
CIK: 1044378 CUSIP: 09072V402 ISIN: US09072V6002 LEI: - UEI: -
Secondary Listings
BIOC has no secondary listings inside our databases.